CYBB and Parkinson disease: Animal model showed that NOX2 is upregulated in several ND as AD, PD, ASL, Huntington's disease, and multiple sclerosis and that apocynin, which is a NOX inhibitor, improved survival and symptoms via decreased neuroinflammation [23].